Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI

NCT06121765 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06121765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06121765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2023
Completion date
November 30, 2025
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cml, chronic phase